Cost-Effectiveness of Intravenous Iron Formulations in Patients with Iron Deficiency Anaemia and Inflammatory Bowel Disease, in a Swedish Regional Setting Using Real-World Tender Prices

Table 7

Results of scenario analyses, FCM compared to FD and IS.

Incremental cost per responder (SEK)	DRG costing		All table-based dosing		All Ganzoni formula
Region	vs. FD	vs. IS	vs. FD	vs. IS	vs. FD	vs. IS
Stockholm	16,804	More effective/less costly	More effective/less costly	More effective/less costly	19,550	More effective/less costly
3-Klöver	16,278	More effective/less costly	615	More effective/less costly	20,210	More effective/less costly
4-Klövern	17,051	More effective/less costly	More effective/less costly	More effective/less costly	24,137	More effective/less costly
JÖK	14,762	More effective/less costly	More effective/less costly	More effective/less costly	20,842	More effective/less costly
Average of selected regions	16,326	More effective/less costly	More effective/less costly	More effective/less costly	15,248	More effective/less costly